US Home - Resources and whitepapers - Whitepapers - Impact of Pre-mix Intravenous Medication in the Pharmacy

Impact of Pre-mix Intravenous Medication in the Pharmacy

Authors

Virginia Mason Institute

Summary

The results from this study show the key differences that compounded products and pre-mix products can make to a hospital and its pharmacy team. It illustrates how compounding can adversely impact workplace wellness and cause further strain on teams who may already be understaffed and on the edge of burnout. This study also evaluates how pre-mixes can alleviate pharmacy technician workload and supply chain challenges currently faced within the industry.

You can download the whitepaper by clicking the link below.

 
Download this whitepaper (PDF)

You are about to be redirected to Xellia’s global website

We are now redirecting you to our global website, click ‘confirm’ below to continue or ‘cancel’ and we will return you to your previous page.

Cancel Confirm